| Kathy J Fabiszewski, NP | |
|
2 Essex Center Dr, Peabody, MA 01960-2926 | |
| (978) 532-2800 | |
| (978) 977-4492 |
| Full Name | Kathy J Fabiszewski |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 44 Years |
| Location | 2 Essex Center Dr, Peabody, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104819051 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 137995 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Hospital Corporation | Beverly, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atrius Health Inc | 4789588641 | 1116 |
News Archive
Controlling mosquitoes that carry human diseases is a global health challenge as their ability to resist insecticides now threatens efforts to prevent epidemics. Scientists from the CNRS, IRD, Université Claude Bernard Lyon 1, Université Joseph Fourier in Grenoble and Institut Pasteur in French Guiana have identified new genetic markers for mosquito resistance to insecticides, which could improve its detection in the field.
An international team of molecular scientists have discovered that star ascidians, also known as sea squirts, have pacemaker cells similar to that of the human heart. The research, published in the JEZ A: Ecological Genetics and Physiology, may offer a new insight into the early evolution of the heart as star ascidians are one of the closest related invertebrates to mammals.
Calling his work "one of the most important findings in breast cancer and health disparities in the last decade," the American Association for Cancer Research (AACR) has named Charles M. Perou, Ph.D. the 2009 Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure-.
The researchers say this effect may improve the success of obesity treatment, especially among people with high insulin secretion (insulin level 30 minutes after consuming a standard amount of glucose).
The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).
› Verified 6 days ago
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
Controlling mosquitoes that carry human diseases is a global health challenge as their ability to resist insecticides now threatens efforts to prevent epidemics. Scientists from the CNRS, IRD, Université Claude Bernard Lyon 1, Université Joseph Fourier in Grenoble and Institut Pasteur in French Guiana have identified new genetic markers for mosquito resistance to insecticides, which could improve its detection in the field.
An international team of molecular scientists have discovered that star ascidians, also known as sea squirts, have pacemaker cells similar to that of the human heart. The research, published in the JEZ A: Ecological Genetics and Physiology, may offer a new insight into the early evolution of the heart as star ascidians are one of the closest related invertebrates to mammals.
Calling his work "one of the most important findings in breast cancer and health disparities in the last decade," the American Association for Cancer Research (AACR) has named Charles M. Perou, Ph.D. the 2009 Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure-.
The researchers say this effect may improve the success of obesity treatment, especially among people with high insulin secretion (insulin level 30 minutes after consuming a standard amount of glucose).
The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathy J Fabiszewski, NP 2 Essex Center Dr, Peabody, MA 01960-2926 Ph: (978) 532-2800 | Kathy J Fabiszewski, NP 2 Essex Center Dr, Peabody, MA 01960-2926 Ph: (978) 532-2800 |
News Archive
Controlling mosquitoes that carry human diseases is a global health challenge as their ability to resist insecticides now threatens efforts to prevent epidemics. Scientists from the CNRS, IRD, Université Claude Bernard Lyon 1, Université Joseph Fourier in Grenoble and Institut Pasteur in French Guiana have identified new genetic markers for mosquito resistance to insecticides, which could improve its detection in the field.
An international team of molecular scientists have discovered that star ascidians, also known as sea squirts, have pacemaker cells similar to that of the human heart. The research, published in the JEZ A: Ecological Genetics and Physiology, may offer a new insight into the early evolution of the heart as star ascidians are one of the closest related invertebrates to mammals.
Calling his work "one of the most important findings in breast cancer and health disparities in the last decade," the American Association for Cancer Research (AACR) has named Charles M. Perou, Ph.D. the 2009 Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure-.
The researchers say this effect may improve the success of obesity treatment, especially among people with high insulin secretion (insulin level 30 minutes after consuming a standard amount of glucose).
The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).
› Verified 6 days ago
Evelyn Marie Dreyer, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Jubilee Dr, Peabody, MA 01960 Phone: 877-341-9606 | |
Mrs. Lindsay Madeline Dicker, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 Centennial Dr, Peabody, MA 01960 Phone: 978-535-1110 Fax: 978-535-2907 | |
Mrs. Gemma Fuller, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2 1st Ave, Peabody, MA 01960 Phone: 617-733-1383 | |
Suzanne B Cinelli, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 229 Andover St, Peabody, MA 01960 Phone: 617-804-6293 | |
Maura A Mcgovern, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 27 Centennial Dr, Peabody, MA 01960 Phone: 978-531-7677 Fax: 978-531-7690 | |
Catherine Crofoot, AGPCNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 172 Newbury St, Peabody, MA 01960 Phone: 978-535-9190 | |
Susan R. Brown-zimmerman, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Zero Centenial Drive, Cab Health And Recovery, Peabody, MA 01960 Phone: 617-247-1001 |